About Rusan Pharma Limited
Data last updated: 10 March 2026
Rusan Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 15 March 1994, the company has been in operation for over 32 years.
Registered with ROC Mumbai under CIN U24230MH1994PLC077069.
Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.84 Cr. Formerly known as Rusan Pharma Private Limited. It is led by directors including Kunal Navin Saxena and Balasaheb Annasaheb Patil.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 58 – D Government Industrial Estate Charkop Kandivali West, Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2025, the company reported a revenue of ₹392.15 Cr, a growth of 9% compared to the previous year.
The company has a workforce of approximately 656 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 2 brands - Rusan Pharma, Aposan. As per MCA filings, the company has open charges of ₹279.97 Cr and satisfied charges of ₹80.83 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rusanpharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address58 – D Government Industrial Estate Charkop Kandivali West, Mumbai, Maharashtra, India – 400067
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Rusan Pharma Limited
Rusan Pharma Limited operates two associated brands: Rusan Pharma and APOSAN. These brands represent Rusan Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing is focused on de-addiction and pain management solutions in India. | rusanpharma.com | |
| APOSAN is focused on Parkinson’s disease treatment solutions. | aposan.in |
Business Activity of Rusan Pharma Limited
Rusan Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Rusan Pharma Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Rusan Pharma Limited
Rusan Pharma Limited is audited by Gupta Saharia & Co. for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Gupta Saharia & Co. | Locked | Locked | Locked |
Complete auditor history for Rusan Pharma Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Rusan Pharma Limited
Rusan Pharma Limited is currently managed by 5 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Kunal Navin Saxena
Also directs:
Navicare Pharma Private Limited, Rusan Health Care Private Limited, Euromed International Private Limited and 5 more
|
Managing Director | 05 Apr 2012 | 14 Years 3 Months | Current |
| Balasaheb Annasaheb Patil | Whole-Time Director | 17 Oct 2012 | 13 Years 8 Months | Current |
| Sandeep Verma | Director | 20 Mar 2023 | 3 Years 3 Months | Current |
|
Navin Satyapal Sexena
Also directs:
Navicare Pharma Private Limited, Rusan Health Care Private Limited, Euromed International Private Limited and 4 more
|
Director | 15 Mar 1994 | 32 Years 3 Months | Current |
|
Aakarsh Navin Saxena
Also directs:
Navin Saxena Research And Technology Private Limited
|
Whole-Time Director | 10 Feb 2016 | 10 Years 5 Months | Current |
Financials of Rusan Pharma Limited FY 2025 filings available
Rusan Pharma Limited reported revenue of ₹392.15 Cr (up 9.00% YoY) for FY 2025.
Ten-year financial statements for Rusan Pharma Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Rusan Pharma Limited
Shareholding and ownership data for Rusan Pharma Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Rusan Pharma Limited
Rusan Pharma Limited has 1 subsidiary company and 6 associated companies. This group structure data is as of FY 2023. The corporate group structure reflects Rusan Pharma Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Tuscany Holdings Private Limited | U65990MH1994PTC081494 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Rusan Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2025 | Others | ₹15 Cr | Open |
| 16 Dec 2022 | Others | ₹10 Cr | Open |
| 27 Jul 2022 | Others | ₹10 Cr | Open |
| 31 Aug 2021 | Canara Bank | ₹75 Cr | Open |
| 29 Sep 2020 | Canara Bank | ₹16.5 Cr | Open |
Total charge records: 15 View all charges
Employees and EPFO Compliance at Rusan Pharma Limited
Rusan Pharma Limited has a workforce of 656 employees as of Apr 05, 2024.
Employee and EPFO history for Rusan Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Rusan Pharma Limited
GST registrations and filing compliance for Rusan Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Rusan Pharma Limited
Credit ratings, litigation, and regulatory alerts for Rusan Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rusan Pharma Limited
MSME payment history for Rusan Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rusan Pharma Limited
Corporate group structure for Rusan Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rusan Pharma Limited
MCA filings and documents for Rusan Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Rusan Pharma Limited
Frequently Asked Questions about Rusan Pharma Limited
Rusan Pharma Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 15 March 1994 (32+ years old) and is registered under CIN U24230MH1994PLC077069. The company has 656 employees.
Rusan Pharma Limited reported revenue of ₹392.15 Cr for FY 2025 (up 9.00% YoY).
The current directors of Rusan Pharma Limited are:
- Kunal Navin Saxena - Managing Director
- Balasaheb Annasaheb Patil - Whole-Time Director
- Sandeep Verma - Director
- Navin Satyapal Sexena - Director
- Aakarsh Navin Saxena - Whole-Time Director
The primary industry of Rusan Pharma Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Rusan Pharma Limited can be reached at the registered office: 58 – D Government Industrial Estate Charkop Kandivali West, Mumbai, Maharashtra, India – 400067, or through the website rusanpharma.com.
The authorised capital is ₹5 Cr, and the paid-up capital is ₹4.84 Cr.